PRESS RELEASE published on 10/22/2025 at 13:30, 2 months 30 days ago Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRIEF published on 10/13/2025 at 13:35, 3 months 8 days ago Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025 Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRIEF published on 10/13/2025 at 13:35, 3 months 8 days ago Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025 Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
PRESS RELEASE published on 10/13/2025 at 13:30, 3 months 8 days ago Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer) Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF published on 10/07/2025 at 13:35, 3 months 14 days ago Medicus Pharma participera au sommet des family offices de Dubaï Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF published on 10/07/2025 at 13:35, 3 months 14 days ago Medicus Pharma to Participate in Dubai Family Office Summit Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE published on 10/07/2025 at 13:30, 3 months 14 days ago Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF published on 09/29/2025 at 13:35, 3 months 22 days ago Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRIEF published on 09/29/2025 at 13:35, 3 months 22 days ago Medicus Pharma Ltd. Gains FDA Support for Skinject Development FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
PRESS RELEASE published on 09/29/2025 at 13:30, 3 months 22 days ago Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026 FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
Published on 01/22/2026 at 05:25, 3 hours 21 minutes ago Sceptre Ventures Announces 10-for-1 Share Consolidation and Non-Brokered Private Placement Offering
Published on 01/22/2026 at 00:00, 8 hours 46 minutes ago Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
Published on 01/22/2026 at 00:00, 8 hours 46 minutes ago FutureGen Industries Provides Shareholder Update on Expanded Investment Strategy in High-Growth Technology Sectors
Published on 01/21/2026 at 23:30, 9 hours 16 minutes ago Galway Metals Reports Robust PEA Results with 33% and 61% After Tax IRR, Using both Long Term and Spot Pricing Scenarios, Respectively
Published on 01/22/2026 at 08:05, 41 minutes ago Gore Street Capital Successfully Completes First Close for its European-Focused Energy Storage Fund
Published on 01/22/2026 at 08:05, 41 minutes ago Redis selects GovTech Campus Deutschland to accelerate public sector digitalisation in Germany
Published on 01/22/2026 at 08:45, 1 minute ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:45, 1 minute ago La démarche proactive d’approvisionnement en électricité bas carbone d’Air Liquide prend de l’ampleur, avec 3 TWh par an de PPA supplémentaires démarrés en 2025
Published on 01/22/2026 at 08:29, 17 minutes ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
Published on 01/22/2026 at 07:00, 1 hour 46 minutes ago 2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Published on 01/22/2026 at 07:00, 1 hour 46 minutes ago Chiffre d'affaires 2025 : 918 M€ à devises constantes (+4.3%) - 899 M€ à devises courantes (+2.1%)